A healthy liver filters all the blood in your body, breaks down toxins and digests fats. It produces collagen to repair damaged cells when the liver is injured. However, a liver can produce too much collagen when an excess accumulation of fat causes chronic inflammation, a condition called metabolic dysfunction-associated steatohepatitis (MASH).
Scientists discover a new signaling pathway and design a novel drug for liver fibrosis retrieved 26 April 2024 from https://medicalxpress.com/news/2024-04-scientists-pathway-drug-liver-fibrosis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Mar 26, 2024Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Sir Ian McKellan and Ted Lasso star team up for Shakespearean West End mash-upITV News' Arts Editor Nina Nannar sat down with Sir Ian and Toheeb Jimoh - who have a six-decade age gap between them.
Read more »
Takeaway lover travels 150 miles to test out 'ridiculous' Blackpool Munch Box'A nice wee mish mash in ya mooth'
Read more »
Scientists link certain gut bacteria to lower heart disease riskChanges in the gut microbiome have been implicated in a range of diseases including type 2 diabetes, obesity, and inflammatory bowel disease. Now, a team of researchers at the Broad Institute of MIT and Harvard along with Massachusetts General Hospital has found that microbes in the gut may affect cardiovascular disease as well.
Read more »
Scientists reveal adipocytes' metabolic role and identify treatment targetsRecent research underscores the critical role of adipocytes in storing fat, vital for organismal survival. Dysfunctional adipocytes can lead to metabolic disorders like type 2 diabetes and fatty liver disease, highlighting the importance of understanding lipid storage mechanisms.
Read more »
Princeton Scientists Unveil Breakthrough in Fusion Reactor TechnologyPrinceton Plasma Physics Laboratory researchers demonstrate the effectiveness of coating fusion reactor vessels with liquid lithium, enhancing plasma stability and fuel efficiency, advancing the quest for practical fusion energy.
Read more »
Scientists pioneer immunotherapy technique for autoimmune diseasesMayo Clinic scientists have developed an immunotherapy strategy that potentially lays the groundwork for treating a spectrum of autoimmune diseases.
Read more »